Area Under the Curve (AUC)
(Redirected from AUClast)
The Area Under the Curve (AUC) is a critical parameter in pharmacokinetics, representing the integral of the drug concentration-time curve. It quantifies the total drug exposure over time, providing vital information on drug absorption, distribution, metabolism, and elimination.
Definition
Where:
- is the drug concentration at time
AUC offers insight into the extent and rate of drug absorption, making it a fundamental measure to assess bioavailability and bioequivalence of drugs.
Types of AUC
Several types of AUC values exist, each serving unique purposes in pharmacokinetic studies:
Type | Description | Application |
---|---|---|
Area under the concentration-time curve up to the last measurable concentration. | Used to determine the total exposure of the body to the drug until the last measurable concentration. | |
Represents the total area under the concentration-time curve from administration to infinity. | Provides an estimate of the total exposure of the body to a drug. Useful for evaluating the overall efficacy of a drug. | |
Area under the concentration-time curve from the administration up to a specific time 't'. | Useful for focusing on drug exposure within specific time windows. | |
Area under the concentration-time curve from administration up to 24 hours. | Often used when drugs are administered once a day. | |
Area under the concentration-time curve over a dosing interval 'tau', for example in repeated dosing every 12 or 24 hours. | Helpful in evaluating steady-state pharmacokinetics in multiple dosing regimens. | |
Utilizes microdosing studies and mass spectrometric analyses to determine the AUC for drugs administered in very low concentrations. | Suitable for studying the pharmacokinetics of drugs at subtherapeutic, micro-level doses. |
Application
AUC is indispensable in pharmacology and drug development:
- It is pivotal for determining the dosage and frequency of drug administration.
- It aids in evaluating the bioequivalence of generic drugs to brand-name counterparts.
- It enables researchers to study the pharmacokinetics of new drug candidates.